Characteristics and clinical relevance of chronic anemia in adult heart transplant recipients

Clinical Transplantation

Volumn 15, Issue 5, 2001, Pages 343-348

  Müller, Helmut M ^a,b   Horina, Jörg H ^b   Kniepeiss, Daniela ^a   Tripolt, Michael B ^a   Stadelbauer, Vanessa ^a   Schweiger, Martin ^a   Tscheliessnigg, Karl Heinz ^a  

^a Division of Transplantation Surgery   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Chronic anemia; Heart transplantation; Survival

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CALCIUM ANTAGONIST; CYANOCOBALAMIN; CYCLOSPORIN A; DIURETIC AGENT; ERYTHROPOIETIN; FAMOTIDINE; FERRITIN; FOLIC ACID; FUROSEMIDE; HEMOGLOBIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IRON; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISOLONE; RANITIDINE; TRANSFERRIN; VITAMIN;

ADULT; ANEMIA; ARTICLE; CLINICAL LABORATORY; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FEMALE; FOLIC ACID DEFICIENCY; GRAFT REJECTION; HEART TRANSPLANTATION; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRON DEFICIENCY; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; RECIPIENT; RETICULOCYTE COUNT; RETROSPECTIVE STUDY; STANDARD; SURVIVAL; VITAMIN DEFICIENCY;

ANEMIA; CASE-CONTROL STUDIES; CHRONIC DISEASE; ERYTHROPOIETIN; FEMALE; FERRITINS; HEART TRANSPLANTATION; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TRANSFERRIN; VITAMINS;

EID: 0034795207     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2001.150507.x     Document Type: Article

References (26)

1. Anemie hemolytique apres transplantation renale [Hemolytic anemia after kidney transplantation]
2. Anemia and erythropoietin levels in lung transplant recipients
3. Anemia and erythropoietin levels in recipients of solid organ transplants
4. Anemia in renal transplant recipients caused by concomitant therapy with azathioprine and angiotensin converting enzyme inhibitors
5. The prevalence, course and characteristics of chronic anemia after heart and lung transplantation
6. Recombinant human erythropoietin may correct erythropoietin-deficient hyporegenerative anaemia in children given cardiac transplantation
7. Erythropoietin deficiency and relative resistance cause anemia in postrenal transplant recipients with normal renal function
8. High prevalence of anemia after cardiac transplantation in children
9. Recombinant human erythropoietin corrects anaemia during the first weeks after renal transplantation: A randomized prospective study
10. Influence of azathioprine on the ferrokinetics of patients with renal failure before and after treatment with erythropoietin
11. Mild chronic anemia following heart transplantation: A syndrome with prognostic relevance?
12. Diurnal levels of immunoreactive erythropoietin in normal subjects and subjects with chronic lung disease
13. Erythropoietin
14. Anaemia in children following cardiac transplantation: Treatment with low dose human recombinant erythropoietin
15. Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient
16. Resistance to recombinant human erythropoietin and kidney graft rejection
17. The determination of plasma transferrin receptor as good index of erythropoietic activity in renal anemia and after renal transplantation
18. Effect of recombinant human erythropoietin therapy in dialysis patients on endogenous erythropoietin synthesis after renal transplantation
19. Factors predisposing to post renal transplant erythrocytosis. A prospective matched-pair control study
20. Immunoreactive erythropoietin in the anemia of non-renal chronic disease
21. Impaired erythropoietin response to anemia after bone marrow transplantation
22. Bone marrow changes following treatment of renal anemia with erythropoietin
23. Progress in understanding the pathogenesis of the anemia of chronic disease
24. Experience of FK506 immune suppression in pediatric heart transplantation: A study of long-term adverse effects
25. Decreased erythropoietin response in patients with the anemia of cancer